Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2228 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
filingDate |
2010-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b5df20c532616bafc9b0490bbfae3f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de97db40474041fdf29ee6b12a6c56d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85c8870cc7f46941278ac65b99e3a965 |
publicationDate |
2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
MX-2012005262-A |
titleOfInvention |
METHOD OF TREATMENT OF HEART FAILURE WITH STRESTRINE TYPE REQUESTS. |
abstract |
The present invention relates to novel methods for the treatment of heart failure, which comprise administering an amount of strescopin-like peptide to a subject in need thereof; and substantially maintaining the amount of said peptide present in the plasma of said subject at a concentration that results in a therapeutic benefit without a substantial increase in the heart rate of said subject; The method comprises the use of strescopin-like peptides that are selective agonists of the type 2 corticotrophin-releasing hormone receptor (CRHR2). |
priorityDate |
2009-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |